🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Viral Infections in Healthy and Immunocompromised Hosts

Recruitingn/aAges 6 Months - 120 YearsAllNational Institute of Allergy and Infectious Dise…
NCT01306084 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Background: \- Viral infections are an important cause of illness and death in hospitalized patients as well as outpatients. New strains of viruses may appear and infect both healthy people and those with weak immune systems. A better understanding of these new virus strains (such as SARS-CoV-2, the virus that causes COVID-19) may help to control and prevent these infections. In particular, some viral infections that are less problematic in healthy persons can be life threatening in persons with weak immune systems, and viruses may be able to evolve more rapidly in persons with weak immune systems and therefore develop resistance to existing treatments. Researchers are interested in collecting samples and information from otherwise healthy persons or persons with weak immune systems to study the effects of viruses and their development. Objectives: \- To collect samples and data from

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
* INCLUSION CRITERIA 1. The protocol is open to people of all ages; 1. Only patients greater than or equal to 2 years of age can be enrolled at the Clinical Center. 2. Patients who are less than 2 years old may be enrolled only remotely and will not be seen at the Clinical Center. 2. a. Persons having (or be suspected of having) a viral infection that is of interest to LID investigators. b. Persons that are a close contact of someone who has (or is suspected of having) a viral infection that is of interest to LID investigators or is about to receive or have recently received a viral vaccine. c. Persons that may have had a recent viral infection that is of interest to LID investigators that has since cleared d. Healthy persons who will serve as controls for (a), (b), or (c) above. These persons will be 18 years of age or older and able to provide informed consent. 3. Adults who are unable to provide initial consent may be enrolled providing procedures per Human Research Protections Program (HRPP) Policy 403 have been followed. 4. Only subjects that are NIH employees or contractors who work at NIH will be enrolled in the COVID19 antibody cohort study on this protocol. EXCLUSION CRITERIA 1. Patients who are unable to safely undergo study procedures and tests. 2. Patients unwilling to have samples collected and stored for future use. 3. For the healthy controls cohort: persons who are \<18 years old, adults who lack decision-making capacity to consent to research participation, and pregnant women
💊

What it tests

  • Not listed
📍

Where

1 site
National Institutes of Health Clinical Center
Bethesda, United States
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy